Wedel
Barbara Wedel, Durham, NC US
Patent application number | Description | Published |
---|---|---|
20110263585 | Screening Assay for Insecticides - The present invention relates to polypeptides, preferably from | 10-27-2011 |
Davin Thomas Wedel, Boston, MA US
Francis X. Wedel, Lake Mills, WI US
Patent application number | Description | Published |
---|---|---|
20090216386 | LOAD SHED TRANSFER MECHANISM AND METHOD - A transfer mechanism and method are provided for transferring the supply of electrical power on a load between a utility source and a stand-by electrical generator wherein load includes an essential load and a secondary load. The transfer mechanism includes a transfer switch that transfers the supply of electrical power to the output between the utility source and the generator. A load shed controller is operatively connected to the output of the transfer switch for monitoring the electrical power supplied to the secondary load. The load shed controller terminates the electrical power supplied to the secondary load in response to the generator being overloaded. | 08-27-2009 |
20110006547 | Method Of Controlling A Variable Speed Constant Frequency Generator - A method of controlling an engine-driven, electrical generator is provided. The generator generates an output voltage at a frequency with the engine running at an operating speed. The method includes the steps of connecting the generator to a load and varying the operating speed of the engine to optimize fuel consumption in response to the load. Thereafter, the frequency of the output voltage is modified to a predetermined level. | 01-13-2011 |
20130270908 | Load Shed Control Module For Use With Electrical Generator - A load management apparatus for use with an electrical system being powered by an electrical generator selectively adds and sheds loads on the electrical generator to prevent overloading of the electrical generator. The load management apparatus learns the load profile for each load during a learning mode and executes one or more load shed processes to control which electrical loads are loading the electrical generator. | 10-17-2013 |
Gregory L. Wedel, Kalamazoo, MI US
Patent application number | Description | Published |
---|---|---|
20110099856 | Shoe device secured to a syphon for removing condensate - A shoe device secured to a syphon is disclosed for removing condensate from an internal surface of a rotating cylinder. The shoe device includes a shoe portion which is disposed adjacent to the internal surface of the rotating cylinder. The shoe portion defines a passageway having an upstream and a downstream end. The passageway permits a flow there through of the condensate from the internal surface of the rotating cylinder, through the upstream end of the passageway to the downstream end of the passageway. The shoe portion has a first and a second side, a surface extending between the first and second sides of the shoe portion. The surface is disposed adjacent to the internal surface of the cylinder. The shoe portion also has a leading and a trailing end and a face extending between the leading and trailing ends of the shoe portion. A clamp is secured to a distal end of the syphon and is connected to the shoe portion for clamping the shoe portion to the syphon. An anchor plate is secured to the clamp and is disposed between the shoe portion and the clamp for anchoring the shoe portion. The arrangement is such that in use of the shoe device, the condensate flows through the passageway through an aperture defined by the anchor plate and through the clamp into the syphon. The shoe portion is fabricated from a material that is softer than the internal surface of the rotating cylinder for inhibiting any wear damage that could otherwise be caused by frictional contact between the shoe portion and the internal surface of the rotating cylinder. | 05-05-2011 |
20120279080 | Turbulence Bar Assembly - A turbulence bar assembly for a cylinder that extends in an axial direction includes a plurality of bars that extend in the axial direction and at least one hoop. The at least one hoop has one or more hoop segments that are connected to the plurality of bars and one or more couplers that are in engagement with the one or more hoop segments to expand and contract a radial dimension of the at least one hoop in response to movement of an adjustment block in the axial direction. | 11-08-2012 |
Johan Martin Wedel, Kavlinge SE
Patent application number | Description | Published |
---|---|---|
20090312077 | FLEXIBLE GASKETS FOR WIRELESS TERMINALS WITH SLIDING MEMBERS - Gaskets and wireless terminals with gaskets for sealing a space between sliding members in wireless terminals. The wireless terminals include: (a) a first member; (b) a second member overlying the first member, wherein at least one of the first and second members is configured to slide between open and closed configurations; and (c) a gasket attached to the first and second members, the gasket having an elongate body portion with opposing first and second end portions affixed to a respective one of the first and second members. The gasket is configured to provide an electrical path between at least one component in the first member to at least one component in the second member. The elongate body portion is configured to snugly abut the first and second members to inhibit dust from entering a target interior space when the wireless terminal is in the open configuration. | 12-17-2009 |
20120149448 | FLEXIBLE GASKETS FOR WIRELESS TERMINALS WITH SLIDING MEMBERS - Gaskets and wireless terminals with gaskets for sealing a space between sliding members in wireless terminals. The wireless terminals include: (a) a first member; (b) a second member overlying the first member, wherein at least one of the first and second members is configured to slide between open and closed configurations; and (c) a gasket attached to the first and second members, the gasket having an elongate body portion with opposing first and second end portions affixed to a respective one of the first and second members. The gasket is configured to provide an electrical path between at least one component in the first member to at least one component in the second member. The elongate body portion is configured to snugly abut the first and second members to inhibit dust from entering a target interior space when the wireless terminal is in the open configuration. | 06-14-2012 |
Mark K. Wedel, Temecula, CA US
Patent application number | Description | Published |
---|---|---|
20090275631 | THERAPEUTIC ANTISENSE OLIGONUCLEOTIDE COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE - Disclosed herein is a method for the sustained amelioration and/or treatment of ulcerative colitis comprising rectal administration of a compound comprising an antisense oligonucleotide having the sequence 5′-GCCCAAGCTGGCATCCGTCA-3′, ISIS 2302. The method results in a decrease in the indications of ulcerative colitis for an extended period (greater than 90 days) after the conclusion of the administration of the composition. The composition is well tolerated and systemic exposure is minimal. | 11-05-2009 |
20100297105 | ADMINISTERING ANTISENSE OLIGONUCLEOTIDES COMPLEMENTARY TO HUMAN APOLIPOPROTEIN B - Methods for long-term lowering of lipid levels in human subjects and for the treatment of conditions associated with elevated LDL-cholesterol and elevated ApoB are provided. | 11-25-2010 |
20120270920 | COMPOSITIONS AND METHODS FOR TREATMENT OF POUCHITIS - The present invention relates methods of treating pouchitis by administering a pharmaceutical formulation suitable for rectal use, such as an enema or suppository, comprising an antisense oligonucleotide targeted to ICAM-1 to an individual | 10-25-2012 |
20130090368 | THERAPEUTIC ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE - Disclosed herein is a method for the sustained amelioration and/or treatment of ulcerative colitis comprising rectal administration of a compound comprising an antisense oligonucleotide having the sequence 5′-GCCCAAGCTGGCATCCGTCA-3′, ISIS 2302. The method results in a decrease in the indications of ulcerative colitis for an extended period (greater than 90 days) after the conclusion of the administration of the composition. The composition is well tolerated and systemic exposure is minimal. | 04-11-2013 |
Martin Wedel, Furulund SE
Patent application number | Description | Published |
---|---|---|
20080280640 | INDUCTIVE JOYSTICK - A portable electronic device includes communication circuitry operative to establish a communication over a communication network, an input device for entering at least one user input into the electronic device, and at least one contactless sensor. The contactless sensor is operative to detect at least one of motion or position of the input device relative to the electronic device. | 11-13-2008 |
20100105451 | SIDE KEY SEAL FOR A PORTABLE ELECTRONIC DEVICE - A seal section for a side key of a portable electronic device is provided contiguously with a main seal. The seal section includes a flexible exterior and an exposed portion, the exposed portion facing the device exterior toward an adjacent side key. The flexible exterior also includes an extension opposite the exposed portion that extends inward toward the interior of the device. When a user depresses a side key, the inward movement of the side key is transmitted through the seal section via the exposed portion and inward extension. The inward movement of the side key is thus transmitted through the seal section to a switching element to convert the manual user input into an electrical input signal command. In this manner, side keys may be sealed without having to provide separate sealing elements, while maintaining the functionality of the side keys. | 04-29-2010 |
Nancy Wedel, Oakland, CA US
Patent application number | Description | Published |
---|---|---|
20080260730 | Treatment of Crohn's disease or psoriasis using anti-interferon gamma antibodies - The present invention provides a method of treating autoimmune diseases. In particular, it provides a method for the treatment of Crohn's disease or psoriasis comprising administering to a subject in need thereof a therapeutically effective amount of an antibody against interferon γ. | 10-23-2008 |
Rebecca L. Wedel, Lawrence, KS US
Patent application number | Description | Published |
---|---|---|
20100292268 | Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use - The present invention provides compositions containing clopidogrel, present as a free base or a pharmaceutically acceptable salt thereof, and sulfoalkyl ether cyclodextrin (SAE-CD). The compositions can be liquid, suspension or solid compositions. They can be adapted for oral, peroral or parenteral administration. The SAE-CD serves to aid in dissolution and stabilization of the clopidogrel in aqueous media. The stability of clopidogrel against hydrolytic degradation, thermal degradation, and photolytic degradation are improved. SAE-CD provides improved results over other cyclodextrin derivatives. The SAE-CD-containing composition of clopidogrel can be provided in liquid form, solid form or as a reconstitutable powder. Both ready-to-use and concentrated liquid compositions can be prepared. The liquid composition is optionally available as a clear solution. The compositions herein can be administered perorally or parenterally and provide substantial pharmacokinetic, pharmacodynamic and/or therapeutic advantages over a tablet composition administered perorally and excluding SAE-CD. | 11-18-2010 |
20130129700 | FORMULATIONS CONTAINING CLOPIDOGREL AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USE - The present invention provides compositions containing clopidogrel, present as a free base or a pharmaceutically acceptable salt thereof, and sulfoalkyl ether cyclodextrin (SAE-CD). The compositions can be liquid, suspension or solid compositions. They can be adapted for oral, peroral or parenteral administration. The SAE-CD serves to aid in dissolution and stabilization of the clopidogrel in aqueous media. The stability of clopidogrel against hydrolytic degradation, thermal degradation, and photolytic degradation are improved. SAE-CD provides improved results over other cyclodextrin derivatives. The SAE-CD-containing composition of clopidogrel can be provided in liquid form, solid form or as a reconstitutable powder. Both ready-to-use and concentrated liquid compositions can be prepared. The liquid composition is optionally available as a clear solution. The compositions herein can be administered perorally or parenterally and provide substantial pharmacokinetic, pharmacodynamic and/or therapeutic advantages over a tablet composition administered perorally and excluding SAE-CD. | 05-23-2013 |
20150025243 | FORMULATIONS CONTAINING CLOPIDOGREL AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USE - The present invention provides compositions containing clopidogrel, present as a free base or a pharmaceutically acceptable salt thereof, and sulfoalkyl ether cyclodextrin (SAE-CD). The compositions can be liquid, suspension or solid compositions. They can be adapted for oral, peroral or parenteral administration. The SAE-CD serves to aid in dissolution and stabilization of the clopidogrel in aqueous media. The stability of clopidogrel against hydrolytic degradation, thermal degradation, and photolytic degradation are improved. SAE-CD provides improved results over other cyclodextrin derivatives. The SAE-CD-containing composition of clopidogrel can be provided in liquid form, solid form or as a reconstitutable powder. Both ready-to-use and concentrated liquid compositions can be prepared. The liquid composition is optionally available as a clear solution. The compositions herein can be administered perorally or parenterally and provide substantial pharmacokinetic, pharmacodynamic and/or therapeutic advantages over a tablet composition administered perorally and excluding SAE-CD. | 01-22-2015 |